Overview

Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)

Status:
Completed
Trial end date:
2019-02-22
Target enrollment:
Participant gender:
Summary
The prompt treatment of pain due to minor trauma is often an unmet need in both Emergency Room Department and Ambulance Rescue. Most of the available drugs are intravenously administered and such route of administration may account for delay in the pain relief onset. Methoxyflurane is an halogenated anesthetic, self-administered by the patient at sub-anesthetic dose through an easy to handle inhaler (Penthrox®). The efficacy and safety of Penthrox® in the treatment of acute traumatic pain will be investigated in an out-of-hospital and in hospital emergency medical care setting.
Phase:
Phase 3
Details
Lead Sponsor:
Mundipharma Pharmaceuticals srl
Collaborator:
Bioikos Ambiente Srl
Treatments:
Acetaminophen
Ketoprofen
Methoxyflurane
Morphine